item management s discussion and analysis of financial condition and results of operations the following discussion contains  in addition to historical information  forward looking statements within the meaning of section a of the securities act of  as amended  which represent the company s expectations or beliefs  including  but not limited to  statements concerning sales of the company s products or services and operating income 
the company cautions that various factors  including  without limitation  the factors discussed below as well as general economic conditions and industry trends  a dependence upon and or loss of key employees  vendors or customers  the loss of strategic product shipping relationships  customer demand  product availability  competition including pricing and availability  concentrations of credit risks  distribution efficiencies  capacity constraints and technological difficulties could cause actual results or outcomes to differ materially from those expressed in any forward looking statements 
new factors emerge from time to time  and it is not possible for management to predict all of such factors 
results of operations net sales and operating income loss 
the following table sets forth the net sales and operating income loss for each segment of the company s business for the last three fiscal years year ended march  in thousands net sales waste management services segment    consumer healthcare products segment    company totals    operating income loss waste management services segment   consumer healthcare products segment corporate    company totals  fiscal vs 
fiscal the company s net sales increased by approximately to  for fiscal from  for fiscal the company s operating income increased to  for fiscal from  in fiscal  an increase of approximately 
the company s cost of goods sold were of net sales in fiscal  which was unchanged as compared to fiscal selling  general  and administrative expenses decreased to of net sales in fiscal from in fiscal the results of operations of the company are dependent upon the results of operations of each of its subsidiaries operating in the individual business segments 
set forth below is a discussion of the results of operations of each of these segments 
waste management services segment net sales in the company s waste management services segment  which operates through bio systems  increased to  in fiscal from  in fiscal the sales growth is primarily due to securing new hospital contracts for bio systems core business of providing sharps including sharp edged medical waste such as scalpels  syringes  and needles disposal services which utilize cost effective reusable containers 
due to cost pressures  hospitals have become more receptive to out sourcing certain services such as sharps management 
additionally  the recent industry trend toward the formation of hospital networks has enhanced bio systems sales and market share growth 
market forces and competitive pricing pressures have affected bio systems ability to increase prices with existing hospital and physician customers 
these factors also impact the prices bio systems is able to charge new and potential customers 
bio systems reported an increase in operating income of to  for fiscal from  for fiscal for fiscal  bio systems cost of goods sold were of its net sales  which was unchanged compared to fiscal selling  general  and administrative expenses decreased to of net sales for fiscal from of net sales for fiscal the decrease in selling  general  and administrative expenses is due to bio systems success in controlling its administrative costs and expenses  such as business liability insurance  combined with a decrease in expenses associated with the purchase of the minority partner s partnership interest in bsp in october see item business acquisition of minority partnership interest 
bio systems capitalized certain costs  primarily legal fees  associated with the purchase of the minority partnership interest in fiscal  while the costs incurred in fiscal associated with the transaction were charged to expense 
additionally  bio systems reduced its bad debt expense in fiscal  even though its net sales increased  primarily due to the implementation of an aggressive collection effort of its accounts receivable 
consumer healthcare products segment net sales for scherer labs  which operates in the company s consumer healthcare products segment  increased to  for fiscal from  for fiscal this slight increase is attributable to a price increase on some of scherer labs products in early fiscal recent consolidation within the industry has negatively impacted the sales of scherer labs products 
as a result of the industry consolidation  some of scherer labs customers have either significantly decreased or discontinued their sales orders for scherer labs products 
scherer labs operating income improved to  for fiscal from  for fiscal for fiscal  scherer labs cost of goods sold decreased to of net sales from of net sales for fiscal this improvement can be attributed to a decrease in cost of materials because scherer labs shipped fewer product units in fiscal  primarily as a result of the industry consolidation discussed above  combined with a favorable inventory reserve adjustment 
selling  general  and administrative expenses decreased slightly to of net sales in fiscal from of net sales in fiscal this improvement is due to a decrease in certain management consulting fees and expenses associated with scherer labs contracted warehouse and distribution facility 
the company intends to begin performing all inventory and shipping functions internally in the second quarter of fiscal by utilizing warehouse space currently leased in one of the company s atlanta  georgia facilities 
corporate the company recorded operating expenses at the corporate level of  and  for fiscal years and  respectively 
certain administrative  accounting  management oversight and payroll services are performed by the company s corporate office 
the corporate operating expenses include the salaries and wages of the personnel who perform these functions  including the company s executive officers  rent expense  and professional accounting and legal fees 
in fiscal  the company recorded approximately  in legal fees associated with litigation that was settled during the year 
the company does not allocate any revenues to the corporate level 
in february  the company relocated its corporate headquarters to another location in atlanta  georgia and will recognize cost savings through reduced rent expense 
fiscal vs 
fiscal the company s net sales increased approximately to  for fiscal from  for fiscal the company s operating income increased approximately to  for fiscal from  for fiscal for fiscal  the company s cost of goods sold increased to of net sales from of net sales for fiscal selling  general  and administrative expenses decreased to of net sales in fiscal from of net sales in fiscal set forth below is a discussion of the results of operations of each of the company s business segments for fiscal compared to fiscal waste management services segment net sales for bio systems increased to  in fiscal from  in fiscal in fiscal  bio systems increased its net sales by approximately  by securing new medical waste disposal contracts with hospitals 
bio systems increased its operating income to  in fiscal from  in fiscal bio systems cost of goods sold increased to of net sales in fiscal from of net sales in fiscal selling  general  and administrative expenses decreased to of net sales in fiscal from in fiscal the improved operating performance can be attributed to the increase in net sales from the acquisition of new hospital contracts combined with a significant decrease in bio systems workers compensation insurance expense 
the decrease in insurance expense is primarily due to the conversion in october of bio systems insurance coverage from a fully insured workers compensation program to a partially insured program  to take advantage of bio systems excellent claims history 
consumer healthcare products segment scherer labs net sales increased approximately to  in fiscal from  in fiscal the increase in net sales can be attributed to securing new customers and retail outlets during fiscal scherer labs improved its operating income to  in fiscal from  in fiscal while improving its net sales by  as discussed above  scherer labs was able to maintain  or improve upon  its prior level of operating costs 
cost of goods sold decreased slightly to of net sales in fiscal from approximately of net sales in fiscal and selling  general and administrative expenses decreased to of net sales in fiscal from in fiscal corporate the company s corporate operating expenses were consistent for fiscal and at  and  respectively 
corporate operating expenses include certain administrative  accounting  management oversight and payroll services 
other income expense 
the company recorded interest income of   and  in fiscal   and  respectively 
the increase in interest income in fiscal is a result of the investment  principally in marketable securities see note of notes to consolidated financial statements included elsewhere herein  of the net proceeds received from the marquest transactions 
in early fiscal  the company used the investments that were collateralizing a line of credit to repay the borrowings it made against the line of credit 
prior to the termination of the line of credit  the company recorded  of interest income from the investments 
additionally  in fiscal  the company was paid in full the outstanding principal amount owed on a certain note receivable that was scheduled to be repaid in monthly installments over several years 
prior to the repayment  the company recorded  in interest income on the note receivable 
the company recorded interest expense of   and  in fiscal   and  respectively 
the decrease in interest expense in fiscal is a result of the repayment of the outstanding principal balance on a note payable to the adult children of an affiliate of the company in july see note of notes to consolidated financial statements included elsewhere herein 
the company used a portion of the proceeds from the marquest transactions to repay in full the note payable 
in fiscal  the company used  of the net proceeds from the sale of the medical business to repay a portion of the outstanding loans from affiliates 
see item business sale of marquest medical products  inc and discontinued medical device and surgical safety disposables segment 
income taxes 
the company recorded an income tax provision of  and  in fiscal and  respectively  and had a tax benefit of  in fiscal in fiscal and  the company utilized tax loss carryforwards and reduced its valuation allowance accordingly 
in fiscal and in prior years  the company significantly increased its valuation allowance against its deferred tax assets mainly related to the tax loss carryforwards 
the company s ability to generate taxable income from operations is dependent upon various factors  many of which are beyond management s control 
accordingly  there can be no assurance that the company will generate future taxable income 
therefore  the realization of the deferred tax assets will be assessed periodically based upon the company s current and anticipated results of operations 
liquidity and capital resources the company s cash and cash equivalents totaled  at march   an increase of  from march  working capital increased to  at march   compared to  at march  the company s long term debt decreased to  at march  from  at march  the primary reasons for these changes are discussed below 
cash flows from operating activities 
the company s cash provided by operating activities from continuing operations totaled  for fiscal  up from  for fiscal bio systems operations provided cash of  for fiscal  compared to  in fiscal the increase can be attributed to bio systems improved operating performance combined with the timing of working capital items  specifically the timing of collections of its accounts receivable 
in fiscal  bio systems implemented an aggressive effort for collection of its trade accounts receivable 
primarily as a result of this collection effort  bio systems improved collection of its accounts receivable by over  for fiscal compared to fiscal scherer labs operations provided cash of  in fiscal  up slightly from  in fiscal cash flows from investing and financing activities 
cash provided by the company s investing activities for fiscal year was  as compared to cash used of  for fiscal this increase is a result of the marquest transactions completed in july as a result of the marquest transactions  the company received  in cash in exchange for its  shares of marquest common stock and  in cash through the exercise of warrants to purchase marquest common stock and the conversion of these shares into cash pursuant to the merger 
additionally  the company received  in cash from the sale of the abg assets to vsi and  in cash for the covenant not to compete with vsi in the manufacture and sale of arterial blood gas products for a period of three years 
the aggregate proceeds that the company received from the merger and the sale of the abg assets  net of transaction costs  were  and the cash held by marquest at the time of the merger was  during the third quarter of fiscal  the company invested approximately  of the proceeds received from the marquest transactions in long term high grade marketable securities 
these marketable securities  which consist of municipal bonds  corporate bonds  and preferred stocks  mature over periods ranging from to years 
the company  through a wholly owned subsidiary  owned a partnership interest in bsp which operates in the company s waste management services segment 
pursuant to a summary judgment  the company s subsidiary was required to purchase the minority partner s partnership interest in bsp valued as of november  after separate appraisals performed by the partners were not consistent  a third independent appraiser was retained by the partners to review each of the previous valuations and to determine the purchase price for the minority interest 
in early october  the independent appraiser informed the company and the minority partner of its determination that the fair market value of the minority interest in bsp was  as of november  effective october   the company s subsidiary purchased  using cash on hand  the minority partner s partnership interest in bsp for a purchase price of  and incurred associated transaction costs of  as a result  the company  through its subsidiary  now owns of bsp 
the company s cash used from financing activities increased to  for fiscal  from  in fiscal this decrease is a result of the repayment in july of the outstanding principal balance of  on a note payable to the adult children of an affiliate of the company 
the note payable was due december   had a fixed monthly payment of  bore interest at prime rate  and was collateralized by  shares of marquest common stock that the company owned 
the company used a portion of the proceeds from the marquest transactions to pay in full the outstanding principal balance of  on the note payable 
the company made installment payments of approximately  against the note payable prior to the repayment 
management of the company believes that its current cash on hand and its current cash flow is sufficient to maintain its current operations 
the company is evaluating its long term options with regard to the use of its remaining cash on hand 

